Clinica - BMS and ImClone to receive biomarker from DxS

Clinica Scrip Scrip Regulatory Affairs Scrip Clinical Research Animal Pharm

Advanced Search

Surgical & Wound care

Cellular & Genetic

Neurological

Other

Clinica

BMS and ImClone to receive biomarker from DxS

02 September 2009

Joseph Harvey

Please Login to read the full article.

Not a subscriber ? Request a FREE Trial Subscribe to Clinica

RELATED CONTENT

NEWS

Clinica News

Magellan offloads microbiology business to Thermo Fisher to focus on clinical Dx
Luminex buys EraGen Biosciences; gains new PCR platform
bioMérieux expands infectious disease test offering with Argene buy ; unexpectedly changes CEO
Response Genetics CEO steps down to focus on R&D

Other Informa News

$935 million Plexxikon buy to bolster Daiichi Sankyo's oncology presence
Ipsen and bioMérieux form personalised medicine partnership

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Market Sector

Business

Policy & Regulation

Regions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm